According to existing data, it is difficult to elucidate whether the levels of FGF19 and/or FGFR4 are indicative of HCC progression and/or the progression of the remaining liver following PH of tumors as well as in livers grafts implanted in the recipient after removing liver with HCC. Here, FGFR4 is linked to hepatocellular carcinoma.